Provided by Tiger Trade Technology Pte. Ltd.

Allogene Therapeutics Inc.

2.05
-0.0800-3.76%
Post-market: 2.090.0379+1.85%18:22 EST
Volume:4.09M
Turnover:8.49M
Market Cap:460.70M
PE:-2.10
High:2.13
Open:2.13
Low:2.03
Close:2.13
52wk High:2.64
52wk Low:0.8621
Shares:224.73M
Float Shares:168.00M
Volume Ratio:0.71
T/O Rate:2.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9781
EPS(LYR):-1.3222
ROE:-54.43%
ROA:-27.34%
PB:1.46
PE(LYR):-1.55

Loading ...

Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 11, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025

Major Issues Report

Form 8-K - Current report
Aug 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 23, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Apr 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities